Clinical trials

  • trastuzumab, pertuzumab for HER2-positive early-stage breast cancer
  • PIRFENIDONE for Progressive pulmonary fibrosis | Pulmonary fibrosis
  • PEMBROLIZUMAB for Pancreatic cancer | Borderline resectable pancreatic cancer | Resectable pancreatic cancer
  • Everolimus for Meningioma (WHO grade 2)|Meningioma (WHO grade 3)|Refractory meningioma
  • sacituzumab tirumotecan for Colorectal cancer | Pancreatic ductal adenocarcinoma | Biliary tract cancer
  • ALN-APP for Early-onset Alzheimer's disease
  • DURVALUMAB for Locoregional hepatocellular carcinoma
  • CD7-CART01 for Relapsed/refractory CD7-positive T-cell acute lymphoblastic leukemia | Relapsed/refractory CD7-positive T-cell lymphoblastic lymphoma
  • SACCHAROMYCES BOULARDII CNCM I-745 (lyophilized) for Erythema migrans (early Lyme borreliosis) | Antibiotic therapy
  • RILIPRUBART for Chronic inflammatory demyelinating polyneuropathy (CIDP)
  • CRIZANLIZUMAB for Sickle cell disease
  • TECLISTAMAB for Multiple myeloma